Panacea Pharmaceuticals, Inc.

Sep 03, 08
	NEW STORY
08:00 ET	Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies
Aug 05, 08
08:00 ET	Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Dec 18, 07
16:18 ET	Panacea Pharmaceuticals' Lung Cancer Diagnostic Test, LC Detect(SM), Named One of Time Magazine's Ten Biggest Medical Breakthroughs of 2007
Dec 11, 07
08:00 ET	Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits
Dec 05, 07
11:19 ET	Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
Nov 14, 07
14:38 ET	Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer
Oct 17, 07
08:00 ET	Panacea Pharmaceuticals Announces the Availability of BC Detect(SM), a Serum- Based Diagnostic Test for Breast Cancer
Jul 19, 07
09:00 ET	Panacea Pharmaceuticals Announces Appointments of Steven A. Fuller, Ph.D. as Vice President, Product Development, and Billie Jo Wood as Director, Clinical Laboratory Services
Jul 17, 07
10:00 ET	Panacea Pharmaceuticals Announces the Availability of LC Detect(sm), a Serum-Based Diagnostic Test for Lung Cancer
May 31, 07
10:00 ET	Panacea Pharmaceuticals Announces the Availability of PC Detect(sm) for Prostate Cancer Screening
Jan 17, 07
10:29 ET	Panacea Pharmaceuticals Initiates Pivotal, Prospective Multi-Center Study to Evaluate the Diagnostic Performance of PC Detect(SM) for Prostate Cancer Screening
Jan 10, 07
10:00 ET	Panacea Pharmaceuticals Appoints Pamela Harris, MD, Vice President Medical and Clinical Affairs
Nov 07, 06
13:32 ET	Panacea Pharmaceuticals' Test Predicts Response to Therapy in Chronic Myelogenous Leukemia
Sep 21, 06
08:00 ET	Panacea Pharmaceuticals Announces Appointments of Christine L. Brauer, Ph.D. as Vice President, Regulatory Affairs; and Jefferey Jones, M.S., as Director of Quality
Sep 12, 06
10:00 ET	Panacea Pharmaceuticals to Present Data on a Novel Cancer Biomarker During AACR Molecular Diagnostics in Cancer Therapeutic Development Meeting
Sep 11, 06
15:00 ET	Panacea Pharmaceuticals Launches CLIA Compliant Diagnostic Testing Laboratory
Jun 28, 06
07:28 ET	Panacea Pharmaceuticals Announces Appointment of Stephen N. Keith, MD, MSPH as President and Chief Operating Officer
Jun 21, 06
13:41 ET	Panacea Pharmaceuticals Announces Award of Phase II SBIR Grant for Pre- Clinical Development of Novel Drug to Treat Ischemic Stroke
Jun 12, 06
10:33 ET	Panacea Pharmaceuticals, Inc. Raises $8.9 Million in Series D Round of Financing
Jul 08, 05
04:10 ET	Panacea Pharmaceuticals, Inc. Raises $7 Million in Series C Round of Financing
May 03, 04
08:18 ET	Panacea Pharmaceuticals, Inc. Announces Collaboration with M.D. Anderson Cancer Center for HAAH Oncology Program
Apr 06, 04
08:56 ET	Panacea Pharmaceuticals, Inc. Awarded SBIR from National Institute of Aging to Develop Neuroprotectants for Stroke and Other Ischemia-Related Conditions
Mar 17, 04
13:13 ET	Panacea Pharmaceuticals, Inc. Announces Collaboration with Walter Reed Army Institute of Research for Pre-Clinical Studies on Drug Candidates for Stroke and Other Neurodegenerative Conditions
Dec 18, 03
09:23 ET	Panacea Pharmaceuticals, Inc. and SRL, Inc. of Tokyo, Japan Announce Agreements to Develop and Commercialize HAAH Based Cancer Diagnostic Tests in Japan
Dec 09, 03
10:08 ET	Panacea Pharmaceuticals, Inc. and JSR Corporation Sign Collaborative Research Agreement for HAAH Cancer Diagnostics
Nov 20, 03
14:04 ET	Panacea Pharmaceuticals, Inc. Announces Presentations Detailing Advances in HAAH Oncology Program
Nov 12, 03
13:11 ET	Panacea Pharmaceuticals, Inc. Presents Data on Several Drug Candidates At Society for Neuroscience 33rd Annual Meeting
Sep 15, 03
08:05 ET	Panacea Pharmaceuticals, Inc. Signs License Agreement with Massachusetts General Hospital/Harvard University for SF-25 Oncology Program
Sep 10, 03
10:06 ET	Panacea Pharmaceuticals, Inc. Announces Extension of Collaboration With Massachusetts Institute of Technology to Engineer Antibodies for HAAH Oncology Program
Jul 07, 03
10:28 ET	Panacea Pharmaceuticals, Inc. Appoints Ambassador Diana Lady Dougan to its Board of Directors
Jun 25, 03
10:19 ET	Panacea Pharmaceuticals, Inc. Announces Appointment Of Bijan Almassian, PhD as Chief Operating Officer
May 13, 03
08:39 ET	Panacea Pharmaceuticals, Inc. Announces Formation of Proteus Diagnostics, Inc. to Develop and Commercialize Cancer Diagnostic Products
May 07, 03
12:12 ET	Panacea Pharmaceuticals, Inc. and Olympus Optical Co., Ltd. Sign Collaborative Research Agreement for MF20 System
Apr 09, 03
12:25 ET	Panacea Pharmaceuticals, Inc. Publishes New Findings on Diagnostic Applications of HAAH Oncology Program
Feb 26, 03
10:10 ET	Panacea Pharmaceuticals, Inc. Announces Opening of New Facility And Launch of New Website
Jan 21, 03
08:09 ET	Panacea Pharmaceuticals, Inc. Appoints Lawrence I. Glass As Chief Strategy Officer
Jan 13, 03
11:35 ET	Panacea Pharmaceuticals, Inc. Appoints Concetta E. Bartosh Vice-President for Legal Affairs
Jan 08, 03
08:04 ET	Panacea Pharmaceuticals, Inc. Announces Extension of Collaboration with Rhode Island Hospital/Brown University for HAAH Oncology Program
Oct 23, 02
07:33 ET	Panacea Pharmaceuticals, Inc. Awarded SBIR Grant From National Cancer Institute to Develop Diagnostic Test for Pancreatic Cancer
Oct 18, 02
09:10 ET	Panacea Pharmaceuticals, Inc. Presents at 3rd World Knowledge Forum In Seoul, South Korea
Aug 29, 02
11:50 ET	Panacea Pharmaceuticals, Inc. Announces Important New Publications Supporting HAAH Oncology Program
Jul 24, 02
11:39 ET	Panacea Pharmaceuticals, Inc. Presents New Findings At 8th International Conference on Alzheimer's Disease and Related Disorders